S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stille AB
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Net Change in Cash
kr56.7m
CAGR 3-Years
119%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Net Change in Cash
-kr499m
CAGR 3-Years
37%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Net Change in Cash
kr60.3m
CAGR 3-Years
-37%
CAGR 5-Years
10%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Net Change in Cash
kr58.8m
CAGR 3-Years
54%
CAGR 5-Years
2%
CAGR 10-Years
14%
Getinge AB
STO:GETI B
Net Change in Cash
-kr2.9B
CAGR 3-Years
N/A
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Net Change in Cash
-kr25m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Net Change in Cash?
Net Change in Cash
56.7m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Net Change in Cash amounts to 56.7m SEK.

What is Stille AB's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
35%

Over the last year, the Net Change in Cash growth was 489%. The average annual Net Change in Cash growth rates for Stille AB have been 119% over the past three years , 35% over the past five years .

Back to Top